tiprankstipranks
Crawford & Company B (CRD.B)
NYSE:CRD.B

Crawford & Company B (CRD.B) AI Stock Analysis

125 Followers

Top Page

CRD.B

Crawford & Company B

(NYSE:CRD.B)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 5.2)
Rating:53Neutral
Price Target:
$10.50
▼(-3.49% Downside)
Action:ReiteratedDate:03/21/26
The score is held back primarily by leveraged balance-sheet risk and weak technical momentum (negative MACD with oversold readings). Offsetting factors are improved recent cash generation and a steady revenue base, while valuation is a mild headwind due to the higher P/E despite a moderate dividend yield.
Positive Factors
Recurring fee‑based business model
Crawford's core revenue comes from fee-based claims administration, TPAs and managed repair services, creating recurring contractual revenue streams. This outsourced-services model produces steady demand from insurers and corporates, supporting durable revenue visibility and client stickiness.
Negative Factors
Elevated leverage
Sustained debt levels two to nearly three times equity raise financial risk and limit strategic flexibility. High leverage increases sensitivity to earnings swings, constrains capital allocation choices and heightens refinancing and covenant risks during weaker operating periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring fee‑based business model
Crawford's core revenue comes from fee-based claims administration, TPAs and managed repair services, creating recurring contractual revenue streams. This outsourced-services model produces steady demand from insurers and corporates, supporting durable revenue visibility and client stickiness.
Read all positive factors

Crawford & Company B (CRD.B) vs. SPDR S&P 500 ETF (SPY)

Crawford & Company B Business Overview & Revenue Model

Company Description
Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, and internationally. The company's Crawford Loss Adjusting provide...
How the Company Makes Money
Crawford & Company primarily makes money by providing fee-based services tied to the handling and administration of insurance claims and related outsourced processes. Key revenue streams generally include: (1) Claims adjusting and claims managemen...

Crawford & Company B Financial Statement Overview

Summary
Mixed fundamentals. Income statement shows stable revenue but uneven growth and thin/volatile profitability (including a 2022 loss and softer recent operating profitability). Balance sheet leverage is a notable risk (debt ~2.0x–2.8x equity in 2022–2024), partially offset by a strong recent cash-flow rebound and improved free cash flow in 2025.
Income Statement
56
Neutral
Balance Sheet
48
Neutral
Cash Flow
71
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.31B1.34B1.32B1.23B1.14B
Gross Profit321.90M367.55M359.07M306.35M291.80M
EBITDA92.62M97.61M102.91M52.11M91.02M
Net Income19.63M26.60M30.61M-18.30M30.69M
Balance Sheet
Total Assets764.30M803.75M799.20M791.51M852.64M
Cash, Cash Equivalents and Short-Term Investments64.08M55.41M58.36M46.01M53.23M
Total Debt270.27M309.49M311.53M346.40M288.67M
Total Liabilities592.87M648.20M659.37M668.13M641.24M
Stockholders Equity173.09M157.21M141.62M124.54M211.97M
Cash Flow
Free Cash Flow92.81M9.97M67.19M-6.96M23.37M
Operating Cash Flow101.85M51.62M103.79M27.63M54.32M
Investing Cash Flow-36.21M-41.65M-36.60M-57.88M-70.83M
Financing Cash Flow-57.62M-12.86M-54.68M25.94M24.66M

Crawford & Company B Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price10.88
Price Trends
50DMA
10.13
Positive
100DMA
10.28
Negative
200DMA
10.12
Positive
Market Momentum
MACD
0.08
Negative
RSI
51.96
Neutral
STOCH
76.39
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CRD.B, the sentiment is Neutral. The current price of 10.88 is above the 20-day moving average (MA) of 9.96, above the 50-day MA of 10.13, and above the 200-day MA of 10.12, indicating a bullish trend. The MACD of 0.08 indicates Negative momentum. The RSI at 51.96 is Neutral, neither overbought nor oversold. The STOCH value of 76.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for CRD.B.

Crawford & Company B Risk Analysis

Crawford & Company B disclosed 24 risk factors in its most recent earnings report. Crawford & Company B reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Crawford & Company B Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
58
Neutral
$502.43M-19.2611.25%2.47%4.39%61.61%
58
Neutral
$115.58M0.9513.52%13.16%
55
Neutral
$41.02M3.504.33%16.79%
53
Neutral
$502.43M28.4011.25%2.47%4.39%61.61%
43
Neutral
$30.14M-0.21-158.66%7.56%-344.04%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CRD.B
Crawford & Company B
10.17
0.24
2.43%
CRD.A
Crawford & Company A
10.42
0.38
3.73%
EHTH
Ehealth
1.32
-4.82
-78.50%
SLQT
SelectQuote
0.66
-2.51
-79.27%
GOCO
GoHealth
1.05
-9.40
-89.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 21, 2026